Table 5 Results of expression of CD68 and M-CSF in tumor versus expression of Ki67 in patients with soft tissue sarcomas, N = 249
From: Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
Expression | Ki67 (%) | Â | ||
|---|---|---|---|---|
| Â | Low | Medium | High | Total |
CD68, Low | 15 (27) | 19 (35) | 21 (38) | 55 (100) |
CD68, High | 15 (9) | 42 (25) | 110 (66) | 167 (100) |
Total | 30 (14) | 61 (28) | 131 (59) | 222 (100) |
Missing | 27 | Â | Chi-Square | 16.947 |
| Â | Â | Â | P-value | <0.001 |
| Â | Low | Medium | High | Total |
M-CSF, Low | 14 (26) | 16 (30) | 23 (43) | 53 (100) |
M-CSF, High | 15 (9) | 41 (25) | 108 (66) | 164 (100) |
Total | 29 (13) | 57 (26) | 131 (60) | 217 (100) |
Missing | 32 | Â | Chi-Square | 12.695 |
| Â | Â | Â | P-value | 0.002 |
| Â | Low | Medium | High | Total |
TGF-beta, Low | 21 (18) | 34 (30) | 59 (52) | 114 (100) |
TGF-beta, High | 7 (6) | 28 (25) | 79 (69) | 114 (100) |
Total | 28 (12) | 62 (27) | 138 (31) | 228 (100) |
Missing | 21 | Â | Chi-Square | 10.749 |
| Â | Â | Â | P-value | 0.005 |